Skip to main content

Published locations for Risankizumab outperforms placebo at 6 months for psoriatic arthritis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Risankizumab outperforms placebo at 6 months for psoriatic arthritis

User login

  • Reset your password
  • /content/risankizumab-outperforms-placebo-6-months-psoriatic-arthritis
  • /edermatologynews/article/248387/psoriatic-arthritis/risankizumab-outperforms-placebo-6-months
  • /familypracticenews/article/248387/psoriatic-arthritis/risankizumab-outperforms-placebo-6-months
  • /internalmedicinenews/article/248387/psoriatic-arthritis/risankizumab-outperforms-placebo-6-months
  • /rheumatologynews/article/248387/psoriatic-arthritis/risankizumab-outperforms-placebo-6-months
  • /rheumatology/article/248387/psoriatic-arthritis/risankizumab-outperforms-placebo-6-months-psoriatic
  • /internalmedicine/article/248387/psoriatic-arthritis/risankizumab-outperforms-placebo-6-months
  • /dermatology/article/248387/psoriatic-arthritis/risankizumab-outperforms-placebo-6-months-psoriatic
  • /familymedicine/article/248387/psoriatic-arthritis/risankizumab-outperforms-placebo-6-months
  • /psoriatic-arthritis-icymi/article/248387/psoriatic-arthritis/risankizumab-outperforms-placebo-6